Robert Blank

Robert Blank is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as Vice President of Strategy for Worldwide Commercial Oncology at Bristol Myers Squibb since June 2020. Prior to this role, Robert held various leadership positions at Merck from January 1992 to May 2020, including Global Disease Area Head for Oncology and Head of Marketing for Oncology. Robert's expertise encompasses multiple facets of marketing and business strategy, with significant achievements such as launching Januvia in Japan and managing various regional and global marketing initiatives for cardiovascular and diabetes products. Academic credentials include an MBA in Finance from Columbia Business School and a degree from Haverford College.